Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Operating Expenses | 1,571 | 3,660 | 1,456 | 1,408 | 1,307 |
| Operating Income | -1,571 | -3,660 | -1,456 | -1,408 | -1,307 |
| Interest Expense | 4 | 4 | 0 | 9 | 8 |
| Other Income | -469 | -187 | 771 | 112 | 552 |
| Pre-tax Income | -2,044 | -3,851 | -686 | -1,305 | -763 |
| Income Tax | 3 | 4 | 2 | 8 | 21 |
| Net Income Continuous | -2,048 | -3,855 | -688 | -1,314 | -784 |
| Net Income | $-2,048 | $-3,855 | $-688 | $-1,314 | $-784 |
| EPS Basic Total Ops | -6.78 | -33.20 | -45.73 | -100.00 | -62.27 |
| EPS Basic Continuous Ops | -6.78 | -33.17 | -47.34 | -98.36 | -62.27 |
| EPS Diluted Total Ops | -6.78 | -33.20 | -45.73 | -100.00 | -62.27 |
| EPS Diluted Continuous Ops | -6.78 | -33.17 | -47.34 | -98.36 | -62.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -33.20 | N/A | -100.00 | -64.00 |
| EBITDA(a) | $-1,569 | $-3,657 | $-1,454 | $-1,405 | $-1,304 |